BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 878495)

  • 1. [Possibilities and limits of tocolytic treatment].
    Brütigam R; Lechner G
    Wien Med Wochenschr; 1977 May; 127(10):320-6. PubMed ID: 878495
    [No Abstract]   [Full Text] [Related]  

  • 2. Atosiban Combined with Ritodrine for Late Threatened Abortion or Threatened Premature Labor Patients with No Response to Ritodrine: A Clinical Trial.
    Fu S; Xie H; Zhong Y; Xu Q; Zhu L; Mo H; Zhang J; Liu Y; Chen H; Zhong Y; Tan J
    Med Sci Monit; 2021 Mar; 27():e929743. PubMed ID: 33731666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ritodrine in the treatment of threatened premature labor. Effects of gas tension and electrolyte balance].
    Qvist N; Sørensen J; Holmskov A
    Ugeskr Laeger; 1983 Jul; 145(27):2080-2. PubMed ID: 6412411
    [No Abstract]   [Full Text] [Related]  

  • 4. [Is surgical-tocolytic prevention and therapy of cervical insufficiency justified without prenatal diagnostic care?].
    Bergner R; Fröhlich HH
    Zentralbl Gynakol; 1977; 99(26):1624-8. PubMed ID: 607700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monitoring of uterine contractions with the use of tocolytic agents (ritodrine). I. Treatment of threatened premature labor].
    Colombo PA; Pittino R; Quaranta S; Sapuppo R
    Ann Ostet Ginecol Med Perinat; 1979; 100(3):187-203. PubMed ID: 475231
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of threatened premature labor by betamimetic drugs: a comparison of fenoterol and ritodrine.
    Richter R; Hinselmann MJ
    Obstet Gynecol; 1979 Jan; 53(1):81-7. PubMed ID: 32502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of early threatened abortion (6th-16th week of pregnancy) using a new tocolytic agent (Th 1165a)].
    Bärmig H; Krzoska C
    Zentralbl Gynakol; 1974 Jan; 96(2):55-8. PubMed ID: 4606038
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tocolytic treatment of pregnant women with threatened abortions and preterm labor in the second and third trimesters of pregnancy with magne B6 (a preliminary communication)].
    Marinov B; Damianov L; Tsache K; Atanasova B
    Akush Ginekol (Sofiia); 1999; 38(1):74-6. PubMed ID: 11965731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectivity of Bricanyl (terbutaline) treatment in the prevention and management of threatening abortion and premature delivery, respectively, within the frames of outpatients' services.
    Tóth B; Avar Z; Bálint T
    Ther Hung; 1982; 30(2):88-92. PubMed ID: 6926911
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hysterographic studies of uterine contractile activity during partusysten treatment of threatened late abortion and premature labor].
    Vinnyts'kyĭ OI
    Pediatr Akus Ginekol; 1979; (4):40-1. PubMed ID: 514659
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical practice evaluation of combination of atosiban, ritodrine and ketoprofen for inhibiting preterm labor.
    Grignaffini A; Soncini E; Ronzoni E; Lo Cane F; Anfuso S; Nardelli GB
    Minerva Ginecol; 2007 Oct; 59(5):481-9. PubMed ID: 17912174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tocolytic substituent treatment with Magnerot in threatened abortions and premature labor from the 16th to the 36th gestational week].
    Damianov L; Negentsov N; Ivanov S; Novachkov V; Tsachev K
    Akush Ginekol (Sofiia); 1995; 34(3):78-81. PubMed ID: 8743863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical trial of Magnerot in the treatment of a threatened abortion after a previous delivery].
    Kavardzhikova S
    Akush Ginekol (Sofiia); 2000; 40(4):54-5. PubMed ID: 11288641
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical use of a beta-mimetic drug in the control of uterine dynamics].
    Casati G; Scaglione V; Vandelli I
    Ann Ostet Ginecol Med Perinat; 1973; 94(9-10):587-94. PubMed ID: 4806144
    [No Abstract]   [Full Text] [Related]  

  • 15. [The pharmacological options for an immediate intervention in threatened premature labor].
    Scarpellini L; Scarpellini F; Spina V
    Clin Ter; 1993 Oct; 143(4):291-4. PubMed ID: 8258262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adrenergic beta receptor agonists in threatened preterm labor].
    Rasmussen OB
    Ugeskr Laeger; 1993 Aug; 155(32):2480-1. PubMed ID: 8102825
    [No Abstract]   [Full Text] [Related]  

  • 17. A prospective, randomized trial of nifedipine vs. ritodrine in threatened preterm labor.
    García-Velasco JA; González González A
    Int J Gynaecol Obstet; 1998 Jun; 61(3):239-44. PubMed ID: 9688484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of premature labour and antagonization of the side effects of tocolytic therapy with verapamil (author's transl)].
    Gummerus M
    Z Geburtshilfe Perinatol; 1977 Oct; 181(5):334-40. PubMed ID: 605642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parotitis due to ritodrine tocolytic treatment for preterm labor.
    Marioni G; Marchese-Ragona R; Ottaviano G; Campobasso C; Staffieri A
    Otolaryngol Head Neck Surg; 2005 Apr; 132(4):665-6. PubMed ID: 15806068
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effectiveness of prolonged uterine relaxation by betamimetic drugs for threatened premature labour (author's transl)].
    Richter R
    Z Geburtshilfe Perinatol; 1978 Dec; 182(6):417-23. PubMed ID: 105481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.